APhA Newsroom

Fast Facts

The American Pharmacists Association is the largest association of pharmacists in the United States advancing the entire pharmacy profession.

Membership: Pharmacists, pharmaceutical scientists, student pharmacists and pharmacy technicians

Governance: 501(c)(6) nonprofit organization, governed by a 15-member Board of Trustees. Its House of Delegates (411 members plus alternates) meets annually to determine overall policy.

Location: Washington, D.C.

Founded: October 6, 1852 in Philadelphia, PA

2020 Annual Report

Media Contact

Taneishia Bundy
APhA Media Relations


Press Releases

View all press releases

Published on Wednesday, March 9, 2022

Pharmacist groups call on Biden Administration to remove limits on prescribing COVID treatments

Modification to EUAs for Oral Antivirals Needed to Achieve Potential of “Test to Treat” Initiative

WASHINGTON, D.C—Today, 14 pharmacy organizations urged the Biden Administration to remove barriers preventing pharmacists from ordering oral antivirals and expand patient access to the “Test to Treat” initiative announced last week during the State of the Union.

In a letter sent to President Biden, the groups called for the removal of a limitation placed on the emergency use authorization (EUA) of COVID-19 antivirals by the Food and Drug Administration (FDA). The limitation prevents pharmacists from ordering the medications. The groups stressed that limitations in the EUAs for COVID oral antivirals mean that patients in rural and underserved communities will be less likely to benefit from the test to treat approach.

“Despite your statement during the State of the Union, Americans who test positive at a pharmacy will only be able to access time-sensitive oral antivirals, on the spot, from a limited number of pharmacies with in-house access to non-pharmacist prescribers, primarily in metropolitan areas,” the groups noted.

Many states license pharmacists to order medications, either independently or in collaboration with a physician. In September, the Department of Health and Human Services authorized pharmacists in all 50 states to order oral treatments for COVID-19. The EUAs issued in December by the FDA specifically prevent pharmacists from ordering oral antivirals.

Pharmacists are clinically trained medication experts and are the primary health care professionals responsible for ensuring safe medication use, including identifying and mitigating drug interactions associated with oral antiviral medications for COVID-19.


  • American Society of Health-System Pharmacists (ASHP)
  • American Association of Colleges of Pharmacy (AACP)
  • American College of Apothecaries (ACA)
  • American College of Clinical Pharmacy (ACCP)
  • Academy of Managed Care Pharmacy (AMCP)
  • American Pharmacists Association (APhA)
  • American Society of Consultant Pharmacists (ASCP)
  • College of Psychiatric and Neurologic Pharmacists (CPNP)
  • Hematology/Oncology Pharmacy Association (HOPA)
  • National Alliance of State Pharmacy Associations (NASPA)
  • National Association of Boards of Pharmacy (NABP)
  • National Community Pharmacists Association (NCPA)
  • National Pharmaceutical Association (NPhA)
  • Society of Infectious Diseases Pharmacists (SIDP)

About APhA
APhA is the only organization advancing the entire pharmacy profession. Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work and advocate for changes that benefit them, their patients, and their communities. For more information, please visit



Rate this article:
No rating
Comments (0)Number of views (4149)
Please login or register to post comments.